2001•Journal of HepatologyRequires access

Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status

Franco Trevisani, Paola Emanuela D'Intino, Antonio Maria Morselli‐Labate, Giuseppe Mazzella, Esterita Accogli, Paolo Caraceni, Marco Domenicali, Stefania De Notariis, E. Roda, Mauro Bernardi

Open publisher page 750 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 750 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Hepatocellular carcinoma, Gastroenterology, Internal medicine, HBsAg, Malignancy, Chronic liver disease, Liver disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status — Research Paper | ScholarLens